Antimicrobial Susceptibility for Helicobacter Pylori Eradication
Fjalë kyçe
Abstrakt
Përshkrim
Usefulness of antimicrobial susceptibility in the eradication of Helicobacter pylori
PURPOSE
Background:
- The rate of eradication of Helicobacter pylori with standard triple therapy (OCA: omeprazole + clarithromycin + amoxicillin) in our area is less than the expected according to the III Maastricht III consensus. However, the current guidelines recommend the use of this therapy.
- According to the Maastricht III consensus, in populations with high rates of clarithromycin resistance (15-20%) another therapy should be considered, or alternatively, testing antimicrobial susceptibility of the H. pylori prior to treatment.
Objectives:
- To clarify the real rate of eradication with OCA therapy with and without antimicrobial susceptibility in our area (with high rate of resistance to clarythromycin).
- To study which is the diagnostic-therapeutic strategy more cost-effective for the treatment of H. pylori.
Design:
- Participants will be screened with a full medical history.
- Participants will aleatory receive OCA therapy empirically, or after antimicrobial susceptibility test if there is no resistance to clarythromycin, for ten days.
- In all cases the eradication of H. pylori will be checked by 13C urea breath test (UBT) in 8 weeks after the therapy have been finished.
- All the adverse event of the therapy will be reported.
Datat
| Verifikuar së fundmi: | 11/30/2011 |
| Paraqitur së pari: | 11/18/2011 |
| Regjistrimi i vlerësuar u dorëzua: | 12/01/2011 |
| Postuar së pari: | 12/05/2011 |
| Përditësimi i fundit i paraqitur: | 12/10/2011 |
| Përditësimi i fundit i postuar: | 12/12/2011 |
| Data e fillimit të studimit aktual: | 01/31/2011 |
| Data e vlerësuar e përfundimit primar: | 10/31/2011 |
| Data e vlerësimit të përfundimit të studimit: | 04/30/2012 |
Gjendja ose sëmundja
Ndërhyrja / trajtimi
Other: OCA 10
Faza
Grupet e krahëve
| Krah | Ndërhyrja / trajtimi |
|---|---|
| Empirical OCA This group will be treated with omeprazole, amoxicillin and clarithromycin without having a previous antibiogram. | |
| OCA after antibiogram This group will be treated with omeprazole, clarithromycin and amoxicillin after an antibiotic susceptibility confirmation. |
Kriteret e pranimit
| Moshat e pranueshme për studim | 18 Years Për të 18 Years |
| Gjinitë e pranueshme për studim | All |
| Metoda e marrjes së mostrës | Probability Sample |
| Pranon Vullnetarë të Shëndetshëm | po |
| Kriteret | Inclusion Criteria: - Diagnosis of H. pylori infection provided by culture, histology or UBT. - Patients need and indication to treat (peptic ulcer disease, firs-degree family history of gastric cancer, MALT lymphoma or dyspeptic symptoms) - Patients must be 18 years or older. Exclusion criteria: - Previous treatment for H. pylori eradication. - Patients who have severe concomitant disease. - Patients who have previous gastric surgery. - Patients who have intolerance to any antimicrobial drugs. |
Rezultati
Masat Kryesore të Rezultateve
1. Number of patients in whom Helicobacter pylori was eradicated. [9 months]
Masat dytësore të rezultateve
1. Number of patient with adverse event [9 months]
2. Cost of the eradication of Helicobacter Pylori in each group. [9 months]
